Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Rapid Engraftment, Immune Cell Reconstitution and Sustained Donor Chimerism in Patients Receiving G-CSF Mobilized Peripheral Blood Stem Cells (PB-SC) from Related or Unrelated Donors Undergoing CD34 Enrichment with Mononuclear Cell (T cell) Addback in Children, Adolescents, and Adults with Malignant and Nonmalignant Diseases

Jordan Milner, Cydney Nichols, Janet Ayello, MS, MT(ASCP), Karen P. Seiter, MD, Delong Liu, MD PhD, Erin Morris, RN, BSN, Sandra Fabricatore, RN, PNP, MSN, Yaya Chu, PhD, Rosemarie Shaw, Carmella van de Ven, MA, Allyson M. Flower, MD, Mitchell S Cairo, MD

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-137668

Published: 2020

Journal Articles

Autologous Hematopoietic Stem Cell Infusion for Myelosuppression after Bcma-CART Therapy in Relapsed Myeloma Patients

Quande Lin, PhD, Lu Han, MS, Jian Zhou, MD PhD, Lina Liu, Master, Yuzhang Liu, master, Fengkuan Yu, Master, YangLi Zhang, Master, Wenli Zuo, Doctor, Keshu Zhou, MD, Baijun Fang, MD, Quanli Gao, Doctor, Xudong Wei, PhD, Delong Liu, MD PhD, Yongping Song, MD PhD

Blood (2019) 134 (Supplement_1): 1851.

https://doi.org/10.1182/blood-2019-128410

Published: 2019

Journal Articles

Thalidomide Combined with Interferons for the Treatment of Recurrent or Refractory Non-Hodgkin's Lymphoma

Fangfang Yuan, MD, Hao Ai, Qingsong Yin, PhD, Lin Chen, MD, Ruihua Mi, Xudong Wei, Yongping Song, MD, Delong Liu, MD PhD

Blood (2018) 132 (Supplement 1): 5341.

https://doi.org/10.1182/blood-2018-99-116131

Published: 2018

Journal Articles

Compound Application of Thalidomide and Recombinant Human Interferon-α-1b, Interleukin-2 in Different Disease Status of Acute Myeloid Leukemia a Multi-Center Prospective Study of a New Combination of Old Drugs

Lin Chen, MD, Ruihua Mi, Xudong Wei, MD PhD, Qingsong Ying, Fangfang Yuan, MD, Lijie Liang, Mengjuan Li, Delong Liu, MD PhD, Yongping Song

Blood (2018) 132 (Supplement 1): 5219.

https://doi.org/10.1182/blood-2018-99-114021

Published: 2018

Journal Articles

Evaluation of Romyelocel-L Myeloid Progenitor Cells to Decrease Infections in De Novo AML Patients Receiving High-Dose Ara-C-Based Induction Therapy

Blood (2018) 132 (Supplement 1): 1407.

https://doi.org/10.1182/blood-2018-99-117231

Published: 2018

Journal Articles

Treatment of Epstein-Barr Virus Associated Central Nervous System Diseases after Allogeneic Hematopoietic Stem Cell Transplantation with Intrathecal Donor Lymphocyte Infusion

Juanjuan Zhao, Yingling Zu, Lu Han, Yanli Zhang, Ruirui Gui, Fengkuan Yu, Zhen Li, Huifang Zhao, Baijun Fang, MD, Quande Lin, Yongping Song, MD, Delong Liu, MD PhD, Jian Zhou, MD PhD

Blood (2018) 132 (Supplement 1): 5685.

https://doi.org/10.1182/blood-2018-99-115742

Published: 2018

Journal Articles

Successful Treatment with Intrathecal Tocilizumab(IL-6 antibody) for 2 Cases of Graft-Versus Host Disease of the Central Nervous System after a Second Allogeneic HSCT from Haploidentical Donor

Ruirui Gui, Juanjuan Zhao, Yingling Zu, Lu Han, MS, Yanli Zhang, Fengkuan Yu, Zhen Li, Huifang Zhao, Baijun Fang, MD, Quande Lin, Quanli Gao, MD, Yongping Song, MD, Jian Zhou, MD PhD, Delong Liu, MD PhD

Blood (2018) 132 (Supplement 1): 5730.

https://doi.org/10.1182/blood-2018-99-117725

Published: 2018

Journal Articles

Development and Evaluation of CART Targeting Bcma with Humanized Alpaca-Derived Single-Domain Antibody As Antigen Recognition Domain

Lu Han, MS, Quanli Gao, MD, Keshu Zhou, MD, Qingsong Yin, PhD, Baijun Fang, MD, Jian Zhou, MD PhD, Xinghu Zhu, MD, Delong Liu, MD PhD, Jishuai Zhang, PhD, Haoyue Du, Hongjian Li, MS, Yongping Song, MD

Blood (2018) 132 (Supplement 1): 1976.

https://doi.org/10.1182/blood-2018-99-114980

Published: 2018

Journal Articles

CLAG-Based Induction Therapy in Previously Untreated High Risk AML Patients

Karen Seiter, MD, Stephanie Germani, FNP, Julie Martin, FNP, Rosemarie Raffa, FNP, Michele Reilly, ANP, Nasir Ahmed, MD, Paul Baskind, Delong Liu, MD PhD

Blood (2015) 126 (23): 4892.

https://doi.org/10.1182/blood.V126.23.4892.4892

Published: 2015

Journal Articles

CAG (cytarabine, aclarubicin, G-CSF) Regimen Is Effective and Well Tolerated in 367 Elderly Patients with AML in China and Japan: A Meta-Analysis

Guoqing Wei, Delong Liu, MD, PhD

Blood (2011) 118 (21): 4290.

https://doi.org/10.1182/blood.V118.21.4290.4290

Published: 2011

Journal Articles

A Meta-Analysis of CAG (cytarabine, aclarubicin, G-CSF) Regimen for the Treatment of 1045 Patients with Leukemia in China and Japan,

Guoqing Wei, Wanmao Ni, MD, Dicky Chiao, PhD, He Huang, Zhen Cai, Delong Liu, MD, PhD

Blood (2011) 118 (21): 3638.

https://doi.org/10.1182/blood.V118.21.3638.3638

Published: 2011

Journal Articles

High Response Rate and Prolonged Survival in Patients with Primary Refractory Acute Myelogenous Leukemia Treated with Decitabine Salvage Therapy

Ana Fernandez, MD, Dhaval Shah, MD, MBBS, Delong Liu, MD, PhD, Nasir Ahmed, MD, Elizabeth Lulaj, MD, Karen Seiter, MD

Blood (2011) 118 (21): 4280.

https://doi.org/10.1182/blood.V118.21.4280.4280

Published: 2011

Journal Articles

Meta-Analysis of CAG (cytarabine, aclarubicin, G-CSF) Regimen for the Treatment of 580 Patients with Acute Leukemia In China and Japan.

Guoqing Wei, MD, PhD, Delong Liu, MD, PhD

Blood (2010) 116 (21): 1064.

https://doi.org/10.1182/blood.V116.21.1064.1064

Published: 2010

Journal Articles

Randomized Phase II Study Evaluating the Efficacy and Safety of Romiplostim Treatment of Patients with Low or Intermediate Risk Myelodysplastic Syndrome (MDS) Receiving Lenalidomide.

Roger M Lyons, Richard A. Larson, MD, Michael A. Kosmo, MD, Sunil Gandhi, Delong Liu, MD, PhD, Marc Chernoff, Luke Dreisbach, MD, Carmen Matei, Kuolong Hu, PhD, Janet L. Franklin, MD, MPH, Dietmar Berger, MD, PhD

Blood (2009) 114 (22): 1770.

https://doi.org/10.1182/blood.V114.22.1770.1770

Published: 2009

Journal Articles

Rasburicase Effectively Lowers Serum Uric Acid Levels in High Risk, Poor Performance Status Patients with Hematologic Malignancies

Doris Ponce, MD, Delong Liu, MD, PhD, Muhammad Rasul, MD, Nasir Ahmed, MD, Marie Dimicco, PhD, Karen Seiter, MD

Blood (2008) 112 (11): 4012.

https://doi.org/10.1182/blood.V112.11.4012.4012

Published: 2008

Journal Articles

Dasatinib Is Associated with Rapid and Durable Complete Hematologic Responses in Patients with Chronic-Phase Chronic Myeloid Leukemia (CPCML).

Delong Liu, MD, PhD, Yousif Matloub, Jaydip Mukhopadhyay, David Liu, Stuart L Goldberg

Blood (2008) 112 (11): 2128.

https://doi.org/10.1182/blood.V112.11.2128.2128

Published: 2008

Journal Articles

Pegylated Recombinant Human Arginase, Rharg-Peg 5,000MW, Targets Cell Cycle Machinery in Multiple Myeloma Cells.

Delong Liu, MD, PhD, Xianghua Lin, MD,PHD, Quanyi Lu, MD,PHD, Thomas Leung, Paul N.M. Cheng, MD, Jen-Wei Chiao, PHD

Blood (2007) 110 (11): 4095.

https://doi.org/10.1182/blood.V110.11.4095.4095

Published: 2007

Journal Articles

Haplo-Identical Allogeneic Stem Cell Transplantation Using GCSF-Mobilized Marrow Plus Blood Stem Cells from Parent Donors for Children with High-Risk Leukemia.

Quanyi Lu, MD, PhD, Xiaoqing Niu, MD, Peng Zhang, MD, Delong Liu, MD, PHD

Blood (2007) 110 (11): 5084.

https://doi.org/10.1182/blood.V110.11.5084.5084

Published: 2007

Journal Articles

A Novel Method of Microarray Quantitave Analysis of P16 CPG Island Methylation in Leukemia Cells from Patients with Hematological Malignancies.

Beiming Shou, MD, Baoan Chen, MD, Dongrui Zhou, Jiahua Ding, MD, Chong Gao, MD, Yunyu Sun, Jun Wang, Jian Chen, Gang Zhao, Yan Ma, Huihui Song, MD, Wen Bao, Xiaoping Pei, Xudong MA, MD, Delong Liu, MD,PHD

Blood (2007) 110 (11): 4140.

https://doi.org/10.1182/blood.V110.11.4140.4140

Published: 2007

Journal Articles

The Epigenetic Effect of Phenylhexyl Isothiocyanate on Histone Acetylation in Patients with Acute Leukemia and Non-Leukemic Disorders.

Liyun Xiao, MD, Xudong Ma, MD, Yiqun Huang, MD, Ruiji Zhen, MD, Xiaoling Ye, MD, Jen-Wei Chiao, PHD, Delong Liu, MD,PHD

Blood (2007) 110 (11): 4145.

https://doi.org/10.1182/blood.V110.11.4145.4145

Published: 2007

NARROW

Autologous Hematopoietic Stem Cell Infusion for Myelosuppression after Bcma-CART Therapy in Relapsed Myeloma Patients

Thalidomide Combined with Interferons for the Treatment of Recurrent or Refractory Non-Hodgkin's Lymphoma

Compound Application of Thalidomide and Recombinant Human Interferon-α-1b, Interleukin-2 in Different Disease Status of Acute Myeloid Leukemia a Multi-Center Prospective Study of a New Combination of Old Drugs

Evaluation of Romyelocel-L Myeloid Progenitor Cells to Decrease Infections in De Novo AML Patients Receiving High-Dose Ara-C-Based Induction Therapy

Treatment of Epstein-Barr Virus Associated Central Nervous System Diseases after Allogeneic Hematopoietic Stem Cell Transplantation with Intrathecal Donor Lymphocyte Infusion

Successful Treatment with Intrathecal Tocilizumab(IL-6 antibody) for 2 Cases of Graft-Versus Host Disease of the Central Nervous System after a Second Allogeneic HSCT from Haploidentical Donor

Development and Evaluation of CART Targeting Bcma with Humanized Alpaca-Derived Single-Domain Antibody As Antigen Recognition Domain

CLAG-Based Induction Therapy in Previously Untreated High Risk AML Patients

CAG (cytarabine, aclarubicin, G-CSF) Regimen Is Effective and Well Tolerated in 367 Elderly Patients with AML in China and Japan: A Meta-Analysis

A Meta-Analysis of CAG (cytarabine, aclarubicin, G-CSF) Regimen for the Treatment of 1045 Patients with Leukemia in China and Japan,

High Response Rate and Prolonged Survival in Patients with Primary Refractory Acute Myelogenous Leukemia Treated with Decitabine Salvage Therapy

Meta-Analysis of CAG (cytarabine, aclarubicin, G-CSF) Regimen for the Treatment of 580 Patients with Acute Leukemia In China and Japan.

Randomized Phase II Study Evaluating the Efficacy and Safety of Romiplostim Treatment of Patients with Low or Intermediate Risk Myelodysplastic Syndrome (MDS) Receiving Lenalidomide.

Rasburicase Effectively Lowers Serum Uric Acid Levels in High Risk, Poor Performance Status Patients with Hematologic Malignancies

Dasatinib Is Associated with Rapid and Durable Complete Hematologic Responses in Patients with Chronic-Phase Chronic Myeloid Leukemia (CPCML).

Pegylated Recombinant Human Arginase, Rharg-Peg 5,000MW, Targets Cell Cycle Machinery in Multiple Myeloma Cells.

Haplo-Identical Allogeneic Stem Cell Transplantation Using GCSF-Mobilized Marrow Plus Blood Stem Cells from Parent Donors for Children with High-Risk Leukemia.

A Novel Method of Microarray Quantitave Analysis of P16 CPG Island Methylation in Leukemia Cells from Patients with Hematological Malignancies.

The Epigenetic Effect of Phenylhexyl Isothiocyanate on Histone Acetylation in Patients with Acute Leukemia and Non-Leukemic Disorders.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only